SnagRx vs He & She MD: Price Lock vs Built-in Coaching
Quick verdict: SnagRx is the lower-cost, price-locked compounded option for patients who prioritize predictable per-dose pricing, while He & She MD is for patients who want coaching and 1:1 clinician access bundled with their GLP-1 plan. This article compares SnagRx vs He & She MD directly on price structure, program support, medication formats, pharmacy and shipping, and regulatory notes.
See SnagRx pricing and details
Price structure and commitment: locked annual pricing vs timed intro rates
SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month as 12-month plan rates; month-to-month equivalents are $99 and $149. SnagRx emphasizes a rate that is “locked flat at every dose” for the life of treatment, meaning the enrolment rate does not increase during titration. He & She MD lists semaglutide injections from $139/month and tirzepatide from $199/month as six-month introductory rates that renew higher after the initial six months. The He & She MD headline prices are promotional and the platform states renewal prices are materially higher after the intro term.
Program support: bare-bones medication delivery vs bundled coaching
SnagRx offers prescription and telemedicine visits included but does not include coaching or nutrition programming. He & She MD bundles its GLP-1 program with a coaching app that includes 1:1 clinician messaging, GLP-1-specific coaching, and progress tracking at no extra cost. If ongoing coaching and clinician messaging are priorities, He & She MD includes those features in its plan; if core objective is predictable medication pricing without bundled coaching, SnagRx emphasizes cost and price stability.
View He & She MD coaching and pricing
Medication formats, compounding, and regulatory notes
Both providers offer compounded GLP-1 medications and include clinician review and prescription as part of the workflow. SnagRx sells compounded semaglutide and tirzepatide and states its medications are compounded in US 503A partner pharmacies; SnagRx notes its compounded medications are not FDA-approved or evaluated by the FDA. He & She MD offers semaglutide injection, oral semaglutide, and tirzepatide injection options, produced in USP-compliant, state-regulated pharmacies, and likewise notes compounded GLP-1s are not reviewed by FDA for safety, efficacy, or quality. Both providers require clinician consultation and state not all customers will qualify for a prescription.
Pharmacy, shipping, and clinician networks
SnagRx names its four US 503A partner pharmacies and partners with OpenLoop Health, a clinician network that covers 48 states. SnagRx states clinician review typically occurs within five hours and approved orders ship next-day via UPS or FedEx in temperature-controlled packaging. He & She MD highlights FDA-regulated pharmacies and free expedited shipping; its marketing states medication ships straight to your door with expedited shipping and no shipping upcharges. Availability and clinician eligibility vary by state for both platforms and specific state coverage is not exhaustively supplied here.
Distinctive differences at a glance
| Criteria | SnagRx | He & She MD |
|---|---|---|
| Starting price | Semaglutide from $69/month (12-month plan) | Semaglutide from $139/month (6-month intro) |
| Price stability | Rate locked flat at every dose for life of treatment | Intro rates renew higher after first six months |
| Program support | Telemed visits included; no coaching | Coaching app with 1:1 clinician messaging included |
| Medication formats | Compounded semaglutide and tirzepatide | Semaglutide injection, oral semaglutide, tirzepatide injection |
| Pharmacy and shipping | Named US 503A pharmacies; next-day UPS/FedEx | USP-compliant pharmacies; free expedited shipping |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not reviewed by FDA |
How eligibility, refunds, and guarantees compare
SnagRx states OpenLoop Health clinicians screen eligibility and will meet with an individual after checkout to determine qualification; SnagRx says a declined prescription is fully refunded and advertises a 6-month weight-loss guarantee with terms. He & She MD also requires clinician consultation and warns not all customers will qualify; He & She MD shows promotional savings for the first six months and specifies renewal pricing but does not supply the same refund or guarantee language in the supplied evidence.
Check SnagRx eligibility and plans
Which provider is best for you?
Choose based on priorities: if predictable, all-in pricing during titration and a bottom-of-market annual plan matter most, SnagRx emphasizes a $69/month semaglutide 12-month plan with price locked at every dose and named US 503A pharmacies. If built-in coaching, 1:1 clinician messaging, and multiple medication formats are your priorities and you accept a time-limited intro price that renews higher, He & She MD bundles those services starting at $139/month for six months.
See if He & She MD fits your needs
Bottom line on SnagRx vs He & She MD
SnagRx vs He & She MD comes down to price predictability versus bundled support. SnagRx is the lower-cost, price-locked compounded offering on a 12-month plan; He & She MD provides coaching and clinician access included in the app with promotional intro rates that renew higher. Review state eligibility and the clinician screening process for either platform before enrolling.
Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan with a rate that is locked flat at every dose and named US 503A pharmacies with next-day shipping.
Choose He & She MD if you want a GLP-1 program that bundles coaching, 1:1 clinician messaging, and progress tracking with medication formats including oral semaglutide and injectable options and you accept six-month intro pricing that renews higher.